Treatment of early rheumatoid arthritis

Karim Raza, Michael Salmon, Christopher Buckley

Research output: Contribution to journalArticlepeer-review

9 Downloads (Pure)


Rheumatoid arthritis is common and leads to joint damage due to persistent synovitis. Aggressive treatment within the first few years after symptom onset, with either disease-modifying antirheumatic drugs or antitumor necrosis factor therapy, reduces the rate of disease progression. There is increasing interest in the concept that the first few months after symptom onset represent a pathologically distinct phase of disease and that this translates into a therapeutic window of opportunity during which it may be possible to switch off the disease process. The rationale for, and difficulties associated with, treatment within this window are discussed.
Original languageEnglish
Pages (from-to)659-68
Number of pages10
Issue number4
Publication statusPublished - 1 Sept 2005


Dive into the research topics of 'Treatment of early rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this